Latest research report on “Medical Radioisotopes Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5614844
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person’s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
This report contains market size and forecasts of Medical Radioisotopes in Global, including the following market information:
Global Medical Radioisotopes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Medical Radioisotopes market was valued at 668.3 million in 2021 and is projected to reach US$ 886.3 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tc-99m Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Radioisotopes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Radioisotopes Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medical Radioisotopes Market Segment Percentages, by Type, 2021 (%)
– Iodine Radioisotopes
Global Medical Radioisotopes Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medical Radioisotopes Market Segment Percentages, by Application, 2021 (%)
– Nuclear Therapy
– Equipment Radioactive Source
Global Medical Radioisotopes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medical Radioisotopes Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Medical Radioisotopes revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Medical Radioisotopes revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– NTP Radioisotopes
– China National Nuclear Corporation
– Eckert & Ziegler Strahlen
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5614844
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441